GENERARE

A scaleable platform for the discovery of novel bioactive molecules from microbes

Generare 

Generare is a drug discovery platform using powerful computational tools & synthetic biology to
efficiently mine microbial genomes for novel bioactive molecules. The startup patents and licenses
high-potential novel molecules to the pharmaceutical industry.

People

      Team leaders

Vincent Libis, CSO

I am interested in using synthetic biology for therapeutic innovation. These days I work on developing methods to rapidly discover novel bioactive microbial metabolites. Molecules of this type play important roles in medicine and they are a key source of antibiotics, anticancer agents or immunosuppressants. I spend most of my time developing sequencing, bioinformatics and molecular biology methods but I also like to think about how we can involve the general public in helping to source new medicines through citizen science projects.

https://www.generare.bio/

vincent.libis@cri-paris.org

 

Guillaume Vandenesch, CEO

guillaume@generare.bio

 

      Our Team

Oriane Monet

Oriane Monet

Engineer

Heloise Georjon

Heloise Georjon

PhD Student

Nadege Guinot

Nadege Guinot

Senior Tech

Baudoin Delepine

Baudoin Delepine

Bioinformatician

Alumni

Eva Adao,
Saif Eloualizi,